Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -76.39% | 2.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -76.39% | 2.79% | |||
| Cost of Revenue | -97.85% | 30.05% | |||
| Gross Profit | -8.69% | -38.14% | |||
| SG&A Expenses | -61.60% | 110.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -127.25% | -59.69% | |||
| Total Operating Expenses | -83.74% | 58.41% | |||
| Operating Income | 101.73% | -589.02% | |||
| Income Before Tax | -71.67% | -10.43% | |||
| Income Tax Expenses | -30.61% | -8.88% | |||
| Earnings from Continuing Operations | -80.05% | -10.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 71.66% | -10.74% | |||
| EBIT | 101.73% | -589.02% | |||
| EBITDA | 109.91% | -301.83% | |||
| EPS Basic | 23.00% | 0.00% | |||
| Normalized Basic EPS | -33.54% | -69.33% | |||
| EPS Diluted | 23.00% | 0.00% | |||
| Normalized Diluted EPS | -33.54% | -69.33% | |||
| Average Basic Shares Outstanding | 39.62% | -10.73% | |||
| Average Diluted Shares Outstanding | 39.62% | -10.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||